Cite
MLA Citation
Mévidette El-Madani et al.. “EVESOR, a model-based, multiparameter, Phase I trial to optimize the benefit/toxicity ratio of everolimus and sorafenib.” Future oncology, vol. 13, 2017, pp. 679–693. http://access.bl.uk/ark:/81055/vdc_100154538226.0x000015